Diagnosticheskoe znachenie immunoekspressii galektina-3, NVME-1 i tsitokeratina-19 v opukholyakh shchitovidnoy zhelezy razlichnogo potentsiala zlokachestvennosti

Abstract

The authors have studied the value of the immunoexpression of galectin-3, HBME-1, and cytokeratin 19 in the diagnosis of 17 benign (follicular adenomas) tumors of the thyrod, 23 malignant tumors (carcinomas of follicular cell origin), and 12 tumors of uncertain malignant potential. The diagnosis based on the analysis of the immuniexpression of galectin-3 and its combination with HBME-1 showed high sensitivity, specificity, and accuracy (96, 88, and 93%, respectively). The tumors of uncertain malignant potential were heterogeneous in the expression of galectin-3 and HBME-1. Coexpression of the above markers may suggest the malignant potential of individual neoplasms included in this group.

Keywords

thyroid tumors / malignant potential / immunohistochemistry

References

[1] Казанцева И. А., Федосенко А. К., Гуревич Л. Е. // Арх. пат. - 2001. - Т. 63, вып. 4. - С. 18-21.

[2] Лушников Е. Ф., Цыб А. Ф., Ямасита С. Рак щитовидной железы в России после Чернобыля. - М., 2006.

[3] Пальцев М. А., Коган Е. А., Тунцова О. И. // Арх. пат. - 1997. - Т. 59, вып. 6. - С. 18-23.

[4] Пальцев М. А., Коган Е. А., Тунцова О. И. и др. // Арх. пат. - 1998. - Т. 60, вып. 3. - С. 5-10.

[5] Юшков П. В., Антонова С. С., Бартолаззи А. // Арх. пат. - 2004. - Т. 66, вып. 6. - С. 39-42.

[6] Arora N., Scognamiglio T., Zhu B. et al. // Wld J. Surg. - 2008. - Vol. 32, N 7. - P. 1237-1246.

[7] Coli A., Bigotti G., Zucchetti F. et al. // Histopathology. - 2002. - Vol. 40, N 1. - P. 80-87.

[8] Fisher S., Asa S. L. // Arch. Pathol. Lab. Med. - 2008. - Vol. 132, N 3. - P. 359-372.

[9] Fonseca E., Soares P., Cardoso-Oliveira M., Sobrinho-Simoes M. // Endocr. Pathol. - 2006. - Vol. 17, N 2. - P. 109-117.

[10] Fontaine J. F., Mirebeau-Prunier D., Franc B. et al. // Oncogene. - 2008. - Vol. 27, N 15. - P. 2228-2236.

[11] Herrmann M. E., LiVolsi V. A., Pasha T. L. et al. // Arch. Pathol. Lab. Med. - 2002. - Vol. 126, N 6. - P. 710-713.

[12] LiVolsi V. A., Albores-Saavedra J., Asa S. L. et al. // World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs / Eds R. A. DeLellis et al. - Lyon, 2004. - P. 57-66.

[13] Mehrotra P., Okpokam A., Buhaidar R. et al. // Histopathology. - 2004. - Vol. 45, N 5. - P. 493-500.

[14] Nascimento M. C., Bisi H., Alves V. A. et al. // Endocr. Pathol. - 2001. - Vol. 12, N 3. - P. 255-257.

[15] Niedziela M., Maceluch J., Korman E. // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87, N 9. - P. 4411-4415.

[16] Oestreicher-Kedem Y., Halpern M., Roizman P. et al. // Head Neck. - 2004. - Vol. 26, N 11. - P. 960-966.

[17] Papotti M., Rodriguez J., De Pompa R. et al. // Mol. Pathol. - 2005. - Vol. 18, N 4. - P. 541-546.

[18] Prasad M. L., Pellegata N. S., Huang Y. et al. // Mod. Pathol. - 2005. - Vol. 18, N 1. - P. 48-57.

[19] Rosai J. // Endocr. Pathol. - 2005. - Vol. 16, N 4. - P. 279- 283.

[20] Scognamiglio T., Hyjek E., Kao J., Chen Y. T. // Am. J. Clin. Pathol. - 2006. - Vol. 126, N 5. - P. 700-708.

[21] Thomas G. A., Williams E. D., Becker D. V. et al. // Clin. Endocrinol. (Oxford). - 2001. - Vol. 55, N 3. - P. 423.

[22] Volante M., Bozzalla-Cassione F., De Pompa R. et al. // Virchows Arch. - 2004. - Vol. 445, N 2. - P. 183-188.

[23] Volante M., Bozzalla-Cassione F., Orlandi F., Papotti M. // Virchows Arch. - 2004. - Vol. 444, N 4. - P. 309-312.

[24] Weber K. B., Shroyer K. R., Heinz D. E. et al. // Am. J. Clin. Pathol. - 2004. - Vol. 122, N 4. - P. 524-531.

[25] Williams E. D. // Int. J. Surg. Pathol. - 2000. - Vol. 8, N 3. - P. 181-183.

RIGHTS & PERMISSIONS

Eco-Vector